IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Pilotto, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.738
AS - Asia 4.681
EU - Europa 3.059
SA - Sud America 1.335
AF - Africa 114
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.558
SG - Singapore 1.847
CN - Cina 1.208
BR - Brasile 1.138
HK - Hong Kong 656
IT - Italia 587
DE - Germania 545
UA - Ucraina 408
VN - Vietnam 348
FR - Francia 309
GB - Regno Unito 246
FI - Finlandia 223
RU - Federazione Russa 215
TR - Turchia 188
IE - Irlanda 166
BD - Bangladesh 107
IN - India 87
CA - Canada 79
AR - Argentina 70
MX - Messico 65
NL - Olanda 60
CZ - Repubblica Ceca 56
PL - Polonia 55
ZA - Sudafrica 50
AT - Austria 46
ID - Indonesia 44
SE - Svezia 37
IQ - Iraq 36
ES - Italia 35
EC - Ecuador 33
CO - Colombia 27
JP - Giappone 27
SA - Arabia Saudita 23
VE - Venezuela 19
BE - Belgio 18
MA - Marocco 16
KE - Kenya 13
CL - Cile 12
EG - Egitto 12
LT - Lituania 12
PK - Pakistan 12
UZ - Uzbekistan 12
PY - Paraguay 11
AZ - Azerbaigian 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
JO - Giordania 8
NP - Nepal 8
UY - Uruguay 8
AU - Australia 7
DO - Repubblica Dominicana 7
PE - Perù 7
PT - Portogallo 7
BO - Bolivia 6
CH - Svizzera 6
CR - Costa Rica 5
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
PA - Panama 5
PH - Filippine 5
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
LV - Lettonia 4
PS - Palestinian Territory 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
BB - Barbados 3
BG - Bulgaria 3
ET - Etiopia 3
GY - Guiana 3
OM - Oman 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
CG - Congo 1
DM - Dominica 1
Totale 16.932
Salva come PNG Salva come JPEG
Città #
Fairfield 884
Singapore 807
Ashburn 722
Hong Kong 653
Woodbridge 575
Houston 399
Seattle 385
Cambridge 327
Jacksonville 317
Beijing 306
Wilmington 296
Ann Arbor 262
New York 251
Princeton 236
Los Angeles 217
Chandler 189
Istanbul 168
Munich 149
Dublin 147
The Dalles 132
Ho Chi Minh City 128
Helsinki 122
Chicago 114
Buffalo 108
Dearborn 97
Des Moines 97
Nanjing 94
São Paulo 94
Brescia 88
Dallas 88
Redondo Beach 88
Milan 82
Moscow 72
San Diego 71
Hanoi 66
Nuremberg 60
Turku 57
San Francisco 55
London 53
Warsaw 53
Shenyang 50
Changsha 43
Shanghai 40
Santa Clara 39
Nanchang 37
Salt Lake City 37
Brno 33
Belo Horizonte 30
Orem 30
Rio de Janeiro 30
Frankfurt am Main 29
Lappeenranta 29
Boardman 28
Montreal 27
Jinan 26
Guangzhou 25
Lancaster 25
Tampa 25
Toronto 25
Brooklyn 24
Chennai 24
Tianjin 24
Atlanta 23
Johannesburg 23
Ningbo 23
Stockholm 23
Vienna 23
Tokyo 22
Hebei 21
Romola 21
Brasília 20
Denver 20
Mexico City 20
Olomouc 20
Brussels 18
Dhaka 18
Elk Grove Village 18
Norwalk 18
Phoenix 18
Poplar 18
Guarulhos 17
Rome 17
Zhengzhou 17
Boston 16
Da Nang 16
Düsseldorf 16
Kunming 16
Verona 16
Porto Alegre 15
Quito 15
Hangzhou 14
Charlotte 13
Jakarta 13
Haiphong 12
Jiaxing 12
Kilburn 12
Kyiv 12
Sterling 12
Campinas 11
Cape Town 11
Totale 10.439
Salva come PNG Salva come JPEG
Nome #
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 267
COVID-19 impact on consecutive neurological patients admitted to the emergency department 213
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 208
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 207
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 201
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 183
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 174
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 169
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 168
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 167
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 163
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 163
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 162
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 161
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 161
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 155
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 155
Vascular risk factors and cognition in Parkinson's disease 153
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 152
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 150
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 148
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 145
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 145
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 144
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 140
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 138
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 135
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 135
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 135
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 133
Central serous chorioretinopathy: Pathogenesis and management 128
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 127
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 127
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 127
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 126
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 126
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 125
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 124
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 124
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 124
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 123
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 121
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 120
Disease-modifying therapies in frontotemporal lobar degeneration. 119
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 119
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 117
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 117
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 116
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 116
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 114
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 114
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 113
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 112
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 111
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 111
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 107
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 103
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 101
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 100
Metabolic patterns across core features in dementia with lewy bodies 99
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 99
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 99
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 98
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 98
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 98
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 97
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 96
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 94
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 94
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 92
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 91
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 91
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 91
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 89
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 88
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 87
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 87
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 86
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 85
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications 83
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 83
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 83
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 83
Dopaminergic deficits along the spectrum of Alzheimer’s disease 82
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 82
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 80
Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions 79
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 79
Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease 78
null 77
A multicentre validation study of the diagnostic value of plasma neurofilament light 77
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study 75
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 75
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies 75
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 75
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 74
Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients 74
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 72
Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies 72
Occipital atrophy signature in prodromal Lewy bodies disease 70
Totale 11.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.137 0 0 0 0 0 261 117 148 162 200 152 97
2021/2022992 98 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20254.065 56 26 47 515 394 261 264 177 488 393 945 499
2025/20264.951 794 1.114 724 1.234 720 365 0 0 0 0 0 0
Totale 17.242